BioPacificVentures concentrates on making selective investments in a small number of companies that are exceptionally innovative.
BioPacificVentures concentrates on making selective investments in a small number of companies that are exceptionally innovative, have a sound business model and possess an experienced management team. Portfolio companies are actively supported by BioPacificVentures at all development stages, from R&D and clinical trial design to product launch and international expansion. Portfolio companies are uniquely positioned to leverage the deep commercial experience and strong network of industry relationships of the BioPacificVentures partners in the global nutrition, pharmaceutical, cosmetics, food and biotech areas.
Announced Date | Fund Name | Money Raised | |
---|---|---|---|
Mar 15, 2005 | BioPacificVentures Fund | $74M |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 28, 2017
Qool Therapeutics
|
Series A | $8M | Biotechnology | — |
Jun 25, 2015
Cadence Biomedical
|
Series B | $1.20M | Biotechnology | — |
Jul 24, 2012
Ocunexus Therapeutics
|
Series B | $20M | Biotechnology | — |
Apr 18, 2011
Ocunexus Therapeutics
|
Series B | $19.20M | Biotechnology | Yes |
Jul 24, 2007
EnCoate
|
Series Unknown | $5.10M | Biotechnology | — |